Medgadget editor Dan Buckland recently paid a visit to Medtronic headquarters, where he met with the company's VP of Medicine and Technology, Dr. Stephen Oesterle, for a talk about where the company and industry is heading.
The company spends about $1.7 billion a year on research and development. As a result, it's planning to release 60 new products next year. It also invests in several smaller companies that are working on products that are interesting or complimentary to its portfolio.
"In interviewing Dr. Oesterle about the future of medical devices, two main themes emerged. He believes that minimally invasive is the future for most surgeries and that everything in the body is electrically active, and hence able to be modulated. He also sees Medtronic as a company that specializes in delivery and implantation. Delivery refers to delivery of both drugs and electricity."
Read the entire post
here.